Title: Clinical Efficacy of Pulveres Fosfomycin Trometamolium plus Zhitong Huazheng Capsule in Treatment of Chronic Pelvic Inflammatory Disease
Abstract: Objective To investigate the clinical effect of Pulveres Fosfomycin Trometamolium plus Zhitong Huazheng Capsule in the treatment of chronic pelvic inflammatory disease.Methods According to random number table,84 patients with chronic pelvic inflammatory disease were divided into trial group and control group,with 42 in each.The patients in the control group were given 3 Capsules of Zhitong Huazheng,3 times a day for 15 days;while those in the trial group were given additional Pulveres Fosfomycin Trometamolium,3g daily for 7 days.The efficacies of patients between the two groups were compared after the end of treatment.Results(1)The symptom score in the trial group was(19.05±3.04) before the treatment and(4.29±1.21) after the treatment;while in the control group was(18.96±3.87) and(8.52±3.47) respectively,with no statistically significant difference before the treatment(P0.05),but with statistically significant difference after the treatment(P0.05).(2) After the treatment,the cured,markedly effective,effective and non-effective cases were respectively 10(23.8%),16(38.1%),12(28.6%),and 4(9.5%) in the trial group;as compared with 6(14.3%),12(28.6%),14(33.3%),and 10(23.8%) in the control group the difference was statistically significant(P0.05).Conclusion Pulveres Fosfomycin Trometamolium plus Zhitong Huazheng Capsule is more effective than single Zhitong Huazheng Capsule in treatment of chronic pelvic inflammatory disease.It is of definite and remarkable effect,with less side-effect.
Publication Year: 2013
Publication Date: 2013-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot